{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:51:13Z","timestamp":1779126673656,"version":"3.51.4"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,10,15]]},"DOI":"10.2169\/internalmedicine.5153-24","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T18:11:48Z","timestamp":1743790308000},"page":"3000-3006","source":"Crossref","is-referenced-by-count":3,"title":["Dyskeratosis Congenita Complicated by Pulmonary Fibrosis and Myelodysplastic Syndrome with a Germline Mutation of the &lt;i&gt;DKC1&lt;\/i&gt; Gene and a Somatic Mutation of the &lt;i&gt;U2AF1&lt;\/i&gt; Gene in Leukocytes"],"prefix":"10.2169","volume":"64","author":[{"given":"Hiroko","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Tsukuba Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tsukuba Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Namiki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tsukuba Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusei","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tsukuba Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihide","family":"Inui","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tsukuba Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tsukuba Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Wakamatsu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Muramatsu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tsukuba Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"#cr-split#-1.1","unstructured":"1. Savage SA, Niewisch MR. Dyskeratosis congenita and related telomere biology disorders. In: GeneReviews<sup>\u00ae<\/sup> [Internet]. In: Adam MP, Feldman J, Mirzaa GM, et al., Eds. University of Washington, Seattle, 1993-2024 [updated 2023 Jan 19"},{"key":"#cr-split#-1.2","unstructured":"cited 2023 Feb 3]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK22301\/"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Niewisch MR, Giri N, McReynolds LJ, et al. Disease progression and clinical outcomes in telomere biology disorders. Blood 139: 1807-1819, 2022.","DOI":"10.1182\/blood.2021013523"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Miwata S, Narita A, Okuno Y, et al. Clinical diagnostic value of telomere length measurement in inherited bone marrow failure syndromes. Haematologica 106: 2511-2515, 2021.","DOI":"10.3324\/haematol.2021.278334"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wang P, Xu Z. Pulmonary fibrosis in dyskeratosis congenita: a case report with a PRISMA-compliant systematic review. BMC Pulm Med 21: 279, 2021.","DOI":"10.1186\/s12890-021-01645-w"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Raghu G, Collard HR, Egan JJ, et al; the ATS\/ERS\/JRS\/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183: 788-824, 2011.","DOI":"10.1164\/rccm.2009-040GL"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cronkhite JT, Xing C, Raghu G, et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med 178: 729-737, 2008.","DOI":"10.1164\/rccm.200804-550OC"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kropski JA, Mitchell DB, Markin C, et al. A novel dyskerin (<i>DKC1<\/i>) mutation is associated with familial interstitial pneumonia. Chest 146: e1-e7, 2014.","DOI":"10.1378\/chest.13-2224"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Parimon T, Yao C, Stripp BR, Noble PW, Chen P. Alveolar epithelial type II cells as drivers of lung fibrosis in idiopathic pulmonary fibrosis. Int J Mol Sci 21: 2269, 2020.","DOI":"10.3390\/ijms21072269"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Savage SA. Dyskeratosis congenita and telomere biology disorders. Hematology Am Soc Hematol Educ Program 2022: 637-648, 2022.","DOI":"10.1182\/hematology.2022000394"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ghanim GE, Fountain AJ, van Roon AM, et al. Structure of human telomerase holoenzyme with bound telomeric DNA. Nature 593: 449-453, 2021.","DOI":"10.1038\/s41586-021-03415-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kanegane H, Kasahara Y, Okamura J, et al. Identification of <i>DKC1<\/i> gene mutations in Japanese patients with X-linked dyskeratosis congenita. Br J Haematol 129: 432-434, 2005.","DOI":"10.1111\/j.1365-2141.2005.05473.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Vuong LG, Hemmati PG, Neuburger S, et al. Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita. Acta Haematol 124: 200-203, 2010.","DOI":"10.1159\/000318721"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ghanim GE, Sekne Z, Balch S, van Roon AM, Nguyen THD. 2.7 \u00c5 cryo-EM structure of human telomerase H\/ACA ribonucleoprotein. Nat Commun 15: 746, 2024.","DOI":"10.1038\/s41467-024-45002-x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Schratz KE, Haley L, Danoff SK, et al. Cancer spectrum and outcomes in the Mendelian short telomere syndromes. Blood 135: 1946-1956, 2020.","DOI":"10.1182\/blood.2019003264"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Perdigones N, Perin JC, Schiano I, et al. Clonal hematopoiesis in patients with dyskeratosis congenita. Am J Hematol 91: 1227-1233, 2016.","DOI":"10.1002\/ajh.24552"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ferrer A, Lasho T, Fernandez JA, et al. Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of <i>U2AF1<\/i> variants. Am J Hematol 98: E357-E359, 2023.","DOI":"10.1002\/ajh.27086"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gutierrez-Rodrigues F, Groarke EM, Thongon N, et al. Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescuing and cancer mutations. Blood 144: 2402-2416, 2024.","DOI":"10.1182\/blood.2024025023"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yoshida H, Park SY, Sakashita G, et al. Elucidation of the aberrant 3&apos; splice site selection by cancer-associated mutations on the <i>U2AF1<\/i>. Nat Commun 11: 4744, 2020.","DOI":"10.1038\/s41467-020-18559-6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Newton CA, Batra K, Torrealba J, et al. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur Respir J 48: 1710-1720, 2016.","DOI":"10.1183\/13993003.00308-2016"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Justet A, Klay D, Porcher R, et al. Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation. Eur Respir J 57: 2003198, 2021.","DOI":"10.1183\/13993003.03198-2020"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Elbadry MI, Tawfeek A, Hirano T, et al. A rare homozygous variant in TERT gene causing variable bone marrow failure, fragility fractures, rib anomalies and extremely short telomere lengths with high serum IgE. Br J Haematol 204: 1086-1095, 2024.","DOI":"10.1111\/bjh.19176"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Womer R, Clark JE, Wood P, Sabio H, Kelly TE. Dyskeratosis congenita: two examples of this multisystem disorder. Pediatrics 71: 603-609, 1983.","DOI":"10.1542\/peds.71.4.603"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/20\/64_5153-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T04:27:19Z","timestamp":1760761639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/20\/64_5153-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":23,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5153-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"5153-24"}}